The shift towards digital technology for clinical research
Remote patient participation and trial monitoring can avoid the high risk of hospital visits
Close log in window
With the whole of pharma in various states of ‘hybridisation’, how can MSLs be supported to deliver enhanced personal service across phy...
The serendipitous nature of face-to-face peer interactions is hard to recreate in digital contexts but a focus on small, two-way interaction...
In our Q&A with Dave Fredrickson, we explore the efforts to continue innovating and bringing better care to cancer patients during and b...
For AstraZeneca’s Alex Bedenkov, investing more in post-pandemic medical capabilities is just the start of a far more profound organisatio...
